Učitavanje...
A real-world study in advanced non-small cell lung cancer with de novo brain metastasis
Brain metastases are the major cause of life-expectancy shortened for patients with lung cancer. The prognostic value of EGFR mutation subtypes and survival benefit of EGFR-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC) patients with de novo brain metastasis is stil...
Spremljeno u:
| Izdano u: | J Cancer |
|---|---|
| Glavni autori: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ivyspring International Publisher
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847653/ https://ncbi.nlm.nih.gov/pubmed/33531991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.51411 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|